AC
NUVB icon

AXQ Capital’s Nuvation Bio NUVB Stock Holding History

AXQ Capital’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$363K Buy
84,710
+73,061
+627% +$407K 0.05% 526
2025
Q4 		$104K Sell
11,649
-105,961
-90% -$656K 0.02% 647
2025
Q3 		$435K Buy
117,610
+22,215
+23% +$60.5K 0.17% 224
2025
Q2 		$186K Buy
+95,395
New +$199K 0.06% 471

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AXQ Capital's NUVB Position: Q1 2026 in Review

AXQ Capital increased its Nuvation Bio (NUVB) stake by 627% in Q1 2026, buying an estimated $407K and bringing the position to 84,710 shares worth $363K. The position accounts for 0.05% of the portfolio, ranked #526.

AXQ Capital first reported a position in NUVB in Q2 2025 and has held it in 4 quarters since. The position peaked at $435K in Q3 2025. 231 funds tracked by Wall St. Rank hold NUVB as of Q1 2026.

  • AXQ Capital held 84,710 shares of Nuvation Bio worth $363K as of Q1 2026.
  • AXQ Capital bought 73,061 Nuvation Bio shares in Q1 2026, an estimated $407K.
  • Nuvation Bio made up 0.05% of AXQ Capital's portfolio in Q1 2026, its #526 holding.
  • AXQ Capital first reported a position in Nuvation Bio in Q2 2025 and has held it in 4 quarters since.
  • AXQ Capital's Nuvation Bio position peaked at $435K in Q3 2025.
  • 231 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2026.

Based on AXQ Capital's 13F filing for Q1 2026, filed 13 May 2026.